Muscogiuri Giovanna, Nuzzo Vincenzo, Gatti Adriano, Zuccoli Alfonso, Savastano Silvia, Di Somma Carolina, Pivonello Rosario, Orio Francesco, Colao Annamaria
Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli "Federico II", via S. Pansini 5, 80131, Naples, Italy.
Internal Medicine Unit, San Gennaro Hospital, Naples, Italy.
Endocrine. 2016 Feb;51(2):268-73. doi: 10.1007/s12020-015-0609-7. Epub 2015 May 1.
Vitamin D (25(OH)D) levels have been associated with cardiovascular disease. Thus, the aim of our study was to investigate the association of 25(OH)D levels with coronary heart disease (CHD) in 698 consecutive type 2 diabetic outpatients. 698 consecutive type 2 diabetic outpatients (25.2 % men, age 66 ± 9 years) and 100 (90 % men, age 65 ± 13 years) age-matched non-diabetic volunteers were enrolled. 25(OH)D assay and the main cardiovascular risk factors were explored. 25(OH)D concentration was 22 ± 10 ng/ml in control subjects and 18.23 ± 10 ng/ml in diabetic patients (p < 0.01). The prevalence of hypovitaminosis D was higher in diabetic patients than in control subjects (90 vs. 83 %, p < 0.01). Diabetic subjects with hypovitaminosis D had higher prevalence of high values of A1C (p < 0.01), BMI (p < 0.01), LDL cholesterol (p < 0.01), triglycerides (p < 0.01), and glycemia (p < 0.01) than their vitamin D-sufficient counterparts. 25(OH)D and HDL cholesterol were lower (p < 0.01), while BMI (p < 0.01), age (p < 0.01), systolic (p < 0.01) and diastolic blood pressure (p < 0.01), diabetes duration (p < 0.01), A1C (p < 0.01), glycemia (p < 0.01), fibrinogen (p < 0.01), triglycerides (p < 0.01), and total (p < 0.01) and LDL cholesterol (p < 0.01) were higher in diabetic subjects with CHD than diabetic subjects without CHD. At the logistic regression analysis, the association of vitamin D with CHD was lost, while sex (p = 0.026), diabetes duration (p = 0.023), and age (p = 0.024) were the most powerful predictors of CHD. The current study demonstrates that 25(OH)D does not have a direct effect on CHD but may have an indirect effect mediated by cardiovascular risk factors such as diabetes duration, age, and sex.
维生素D(25羟维生素D)水平与心血管疾病有关。因此,我们研究的目的是调查698例连续2型糖尿病门诊患者中25羟维生素D水平与冠心病(CHD)之间的关联。纳入了698例连续的2型糖尿病门诊患者(男性占25.2%,年龄66±9岁)以及100例年龄匹配的非糖尿病志愿者(男性占90%,年龄65±13岁)。对25羟维生素D检测及主要心血管危险因素进行了探究。对照组受试者的25羟维生素D浓度为22±10 ng/ml,糖尿病患者为18.23±10 ng/ml(p<0.01)。糖尿病患者维生素D缺乏症的患病率高于对照组(90%对83%,p<0.01)。与维生素D充足的糖尿病受试者相比,维生素D缺乏的糖尿病受试者糖化血红蛋白(A1C)、体重指数(BMI)、低密度脂蛋白胆固醇、甘油三酯及血糖值偏高的患病率更高(p均<0.01)。与无冠心病的糖尿病受试者相比,有冠心病的糖尿病受试者25羟维生素D和高密度脂蛋白胆固醇更低(p<0.01),而BMI(p<0.01)、年龄(p<0.01)、收缩压(p<0.01)和舒张压(p<0.01)、糖尿病病程(p<0.01)、A1C(p<0.01)、血糖(p<0.01)、纤维蛋白原(p<0.01)、甘油三酯(p<0.01)以及总胆固醇(p<0.01)和低密度脂蛋白胆固醇(p<0.01)更高。在逻辑回归分析中,维生素D与冠心病之间的关联消失,而性别(p=0.026)、糖尿病病程(p=0.023)和年龄(p=0.024)是冠心病最有力的预测因素。当前研究表明,25羟维生素D对冠心病没有直接影响,但可能通过糖尿病病程、年龄和性别等心血管危险因素产生间接影响。